Analysis of PorA variable region 3 in meningococci: Implications for vaccine policy?

Vaccine

Volumn 21, Issue 19-20, 2003, Pages 2468-2473

  Clarke, S C ^a,b   Diggle, M A ^a   Molling P ^c   Unemo, M ^c   Olcen P ^c  

^a STOBHILL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Meningococci; Neisseria meningitidis; porA; Sequence typing; Vaccine

Indexed keywords

OUTER MEMBRANE PROTEIN; VACCINE;

ALLELE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; GENE; GENETIC ANALYSIS; GENOTYPE; IMMUNOGLOBULIN VARIABLE REGION; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLICY; PORA GENE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SWEDEN; UNITED KINGDOM;

EID: 0037726798     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00033-1     Document Type: Article

References (36)

1. Ala'Aldeen A.A., Cartwright K.A. Neisseria meningitidis: vaccines and vaccine candidates. J. Infect. 33:1996;153-157.
2. Arhin F.F., Moreau F., Coulton J.W., Mills E.L. Sequencing of porA from clinical isolates of Neisseria meningitidis defines a subtyping scheme and its genetic regulation. Can. J. Microbiol. 44:1998;56-63.
3. Cartwright K., Morris R., Rumke H., Fox A., Borrow R., Begg N.et al. Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins. Vaccine. 17:1999;2612-2619.
4. Clarke S.C., Diggle M.A., Edwards G.F. Semiautomation of multilocus sequence typing for the characterization of clinical isolates of Neisseria meningitidis. J. Clin. Microbiol. 39:2001;3066-3071.
5. Clarke S.C., Diggle M.A., Reid J.A., Thom L., Edwards G.F. Introduction of an automated service for the laboratory confirmation of meningococcal disease in Scotland. J. Clin. Pathol. 54:2001;556-557.
6. Connolly M., Noah N. Is group C meningococcal disease increasing in Europe? A report of surveillance of meningococcal infection in Europe 1993-1996. European Meningitis Surveillance Group. Epidemiol. Infect. 122:1999;41-49.
7. de Kleijn E.D., de Groot R., Lafeber A.B., Labadie J., van Limpt K.C., Visser J.et al. Immunogenicity and safety of monovalent P1.7(h), 4 meningococcal outer membrane vesicle vaccine in toddlers: comparison of two vaccination schedules and two vaccine formulations. Vaccine. 19:2000;1141-1148.
8. Eldridge J., Sutcliffe E.M., Abbott J.D., Jones D.M. Serological grouping of meningococci and detection of antigen in cerebrospinal fluid by coagglutination. Med. Lab. Sci. 35:1978;63-66.
9. Enright M.C., Spratt B.G. Multilocus sequence typing. Trends Microbiol. 7:1999;482-487.
10. Finne J., Bitter-Suermann D., Goridis C., Finne U. An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues. J. Immunol. 138:1987;4402-4407.
11. Hayrinen J., Jennings H., Raff H.V., Rougon G., Hanai N., Gerardy-Schahn R.et al. Antibodies to polysialic acid and its N-propyl derivative: binding properties and interaction with human embryonal brain glycopeptides. J. Infect. Dis. 171:1995;1481-1490.
12. Maiden M.C., Bygraves J.A., McCarvil J., Feavers I.M. Identification of meningococcal serosubtypes by polymerase chain reaction. J. Clin. Microbiol. 30:1992;2835-2841.
13. Maiden M.C., Russell J., Suker J., Feavers I.M. Neisseria meningitidis subtype nomenclature. Clin. Diagn. Lab. Immunol. 6:1999;771-772.
14. Maiden M.C., Suker J., McKenna A.J., Bygraves J.A., Feavers I.M. Comparison of the class 1 outer membrane proteins of eight serological reference strains of Neisseria meningitidis. Mol. Microbiol. 5:1991;727-776.
15. McGuinness B.T., Lambden P.R., Heckels J.E. Class 1 outer membrane protein of Neisseria meningitidis: epitope analysis of the antigenic diversity between strains, implications for subtype definition and molecular epidemiology. Mol. Microbiol. 7:1993;505-514.
16. Molling P., Backman A., Olcen P., Fredlund H. Comparison of serogroup W135 meningococci isolated in Sweden during a 23-year period and those associated with a recent hajj pilgrimage. J. Clin. Microbiol. 39:2001;2695-2699.
17. Molling P., Unemo M., Backman A., Olcen P. Genosubtyping by sequencing group A, B and C meningococci; a tool for epidemiological studies of epidemics, clusters and sporadic cases. APMIS. 108:2000;509-516.
18. Olcen P., Danielsson D., Kjellander J. The use of protein A-containing staphylococci sensitized with anti-meningococcal antibodies for grouping Neisseria meningitidis and demonstration of meningococcal antigen in cerebrospinal fluid. Acta. Pathol. Microbiol. Scand. B. 83:1975;387-396.
19. Peeters C.C., Rumke H.C., Sundermann L.C., Rouppe van der Voort E.M., Meulenbelt J., Schuller M.et al. Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine. Vaccine. 14:1996;1009-1015.
20. Perkins B.A., Jonsdottir K., Briem H., Griffiths E., Plikaytis B.D., Hoiby E.A.et al. Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland. J. Infect. Dis. 177:1998;683-691.
21. Rappuoli R. Conjugates and reverse vaccinology to eliminate bacterial meningitis. Vaccine. 19:2001;2319-2322.
22. Riesbeck K., Orvelid-Molling P., Fredlund H., Olcen P. Long-term persistence of a discotheque-associated invasive Neisseria meningitidis group C strain as proven by pulsed-field gel electrophoresis and porA gene sequencing. J. Clin. Microbiol. 38:2000;1638-1640.
23. Rosenqvist E., Hoiby E.A., Wedege E., Bryn K., Kolberg J., Klem A.et al. Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine. Infect. Immun. 63:1995;4642-4652.
24. Rosenstein N.E., Fischer M., Tappero J.W. Meningococcal vaccines. Infect. Dis. Clin. North. Am. 15:2001;155-169.
25. Rouppe van der Voort E.M., Schuller M., Holst J., de Vries P., van der Ley P., van den Dobbelsteen G.et al. Immunogenicity studies with a genetically engineered hexavalent PorA and a wild-type meningococcal group B outer membrane vesicle vaccine in infant cynomolgus monkeys. Vaccine. 18:2000;1334-1343.
26. Sacchi C.T., Lemos A.P., Brandt M.E., Whitney A.M., Melles C.E., Solari C.A.et al. Proposed standardization of Neisseria meningitidis PorA variable-region typing nomenclature. Clin. Diagn. Lab. Immunol. 5:1998;845-855.
27. Spratt B.G. Multilocus sequence typing: molecular typing of bacterial pathogens in an era of rapid DNA sequencing and the internet. Curr. Opin. Microbiol. 2:1999;312-316.
28. Suker J., Feavers I.M., Achtman M., Morelli G., Wang J.F., Maiden M.C. The porA gene in serogroup A meningococci: evolutionary stability and mechanism of genetic variation. Mol. Microbiol. 12:1994;253-265.
29. Tappero J.W., Lagos R., Ballesteros A.M., Plikaytis B., Williams D., Dykes J.et al. Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile. J. Am. Med. Assoc. 281:1999;1520-1527.
30. Tsai C.M., Frasch C.E., Mocca L.F. Five structural classes of major outer membrane proteins in Neisseria meningitidis. J. Bacteriol. 146:1981;69-78.
31. Tzanakaki G., Urwin R., Musilek M., Kriz P., Kremastinou J., Pangalis A.et al. Phenotypic and genotypic approaches to characterization of isolates of Neisseria meningitidis from patients and their close family contacts. J. Clin. Microbiol. 39:2001;1235-1240.
32. van der Ley P., Heckels J.E., Virji M., Hoogerhout P., Poolman J.T. Topology of outer membrane porins in pathogenic Neisseria spp. Infect. Immun. 59:1991;2963-2971.
33. van der Ley P., Poolman J.T. Construction of a multivalent meningococcal vaccine strain based on the class 1 outer membrane protein. Infect. Immun. 60:1992;3156-3161.
34. Rouppe van der Voort E.M., van der Ley P., van der Biezen J., George S., Tunnela O., van Dijken H.et al. Specificity of human bactericidal antibodies against PorA P1.7, 16 induced with a hexavalent meningococcal outer membrane vesicle vaccine. Infect. Immun. 64:1996;2745-2751.
35. Wedege E., Michaelsen T.E. Human immunoglobulin G subclass immune response to outer membrane antigens in meningococcal group B vaccine. J. Clin. Microbiol. 25:1987;1349-1353.
36. Yakubu D.E., Abadi F.J., Pennington T.H. Molecular typing methods for Neisseria meningitidis. J. Med. Microbiol. 48:1999;1055-1064.